Application no. and date | 13189441.2 (espacenet) (Federated) (European Patent Register), 20060725 | Patent/reg. no. and date | DK/EP 2719384, 20180808 | Publication date | 20140416 | Priority no. and date | US 703364 P, 20050727 | EP pub. no. and date |
EP 2719384 20140416 | Effective date | | Applicant/owner | Otsuka America Pharmaceutical, Inc., 2440 Research Boulevard
Rockville, MD 20850, US | Applicant ref. no. | Otsuka 575758 | Inventor | Chen, Zhengming, 11 Hudnut Lane
Belle Mead, NJ 08502, US, EPSTEIN, Joseph W., 19 Briarwood Avenue
Monroe, NY 10950, US, Skolnick, Phil, 12500 Park Potomac Avenue Unit 906
Potomac, MD 20854, US, Basile, Anthony, 6168 Creekside Drive
Flourtown, PA 19031, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 31/40 (2006.01) , A61P 25/00 (2006.01) , C07D 209/52 (2006.01) | Title | Hidtil ukendte præparater med 1-naphthyl-3-azabicyclo[3.1.0]hexaner og anvendelse til behandling af neuropsykiatriske lidelser. | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|